Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARHGAP27P1-BPTFP1-KPNA2P3 readthrough, transcribed pseudogene is a naturally occurring readthrough between three unprocessed pseudogene loci on human chromosome 17. It is annotated as a non-coding RNA and is classified as both a pseudogene and a transcribed readthrough product. It does not encode a protein and its biological function, if any, is unknown. There is no evidence it acts as a therapeutic target, biomarker, or is involved in drug mechanism of action. Pseudogenes are typically considered non-functional remnants of genes, although in rare cases some lncRNAs are reported to have regulatory functions; no such data exists for this locus[3][5][7][9][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARHGAP27P1-BPTFP1-KPNA2P3 readthrough, transcribed pseudogene (ARHGAP27P1-BPTFP1-KPNA2P3).